These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 1972648)
1. Effect of cetirizine in a conjunctival provocation test with allergens. Schoeneich M; Pécoud AR Clin Exp Allergy; 1990 Mar; 20(2):171-4. PubMed ID: 1972648 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of cetirizine in the treatment of seasonal allergic rhinoconjunctivitis. Panayotopoulos SM; Panayotopoulou ES Ann Allergy; 1990 Aug; 65(2):146-8. PubMed ID: 1974401 [TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model. Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587 [TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of cetirizine]. Tarchalska-Kryńska B; Zawisza E Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):123-6. PubMed ID: 1977153 [TBL] [Abstract][Full Text] [Related]
6. Effect of levocabastine, a new H1 antagonist, in a conjunctival provocation test with allergens. Zuber P; Pécoud A J Allergy Clin Immunol; 1988 Oct; 82(4):590-4. PubMed ID: 2902114 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of mequitazine in comparison with placebo assessed by ocular challenge with allergen in allergic conjunctivitis. Persi L; Dupin O; Arnaud B; Trinquand C; Michel FB; Bousquet J Allergy; 1997 Apr; 52(4):451-4. PubMed ID: 9188930 [TBL] [Abstract][Full Text] [Related]
8. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test. Pécoud A; Zuber P; Kolly M Int Arch Allergy Appl Immunol; 1987; 82(3-4):541-3. PubMed ID: 2883132 [TBL] [Abstract][Full Text] [Related]
10. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine. Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006 [TBL] [Abstract][Full Text] [Related]
11. Comparison of effects of topical levocabastine and nedocromil sodium on the early response in a conjunctival provocation test with allergen. Hammann C; Kämmerer R; Gerber M; Spertini F J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1045-50. PubMed ID: 8977503 [TBL] [Abstract][Full Text] [Related]
12. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH; Briscoe M; Widlitz MD J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501 [TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Falliers CJ; Brandon ML; Buchman E; Connell JT; Dockhorn R; Leese PT; Miller J; Wasserman SI; Zeterberg JM; Altman R Ann Allergy; 1991 Mar; 66(3):257-62. PubMed ID: 1672494 [TBL] [Abstract][Full Text] [Related]
14. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen. Dake Y; Enomoto T; Cheng L; Enomoto K; Shibano A; Ikeda H; Yoda S; Yajin S; Sakota T; Yamanishi E Allergol Int; 2006 Dec; 55(4):373-8. PubMed ID: 17130679 [TBL] [Abstract][Full Text] [Related]
15. Astemizole and cetirizine in the treatment of seasonal allergic rhinitis: a comparative double-blind, multicentre study. Rijntjes E; Ghys L; Rihoux JP J Int Med Res; 1990; 18(3):219-24. PubMed ID: 1972927 [TBL] [Abstract][Full Text] [Related]
16. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial. Crampton HJ Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545 [TBL] [Abstract][Full Text] [Related]